
Sign up to save your podcasts
Or
Pfizer and Moderna have developed new vaccines designed to target COVID's omicron mutation. Both manufacturers have asked the U.S. Food and Drug Administration to green-light their versions of the jab, which could be made available in September. In this week's episode, I speak with Dr. Christopher Doehring, vice president of medical affairs at Franciscan Health, to get his reaction to the news.
See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
5
11 ratings
Pfizer and Moderna have developed new vaccines designed to target COVID's omicron mutation. Both manufacturers have asked the U.S. Food and Drug Administration to green-light their versions of the jab, which could be made available in September. In this week's episode, I speak with Dr. Christopher Doehring, vice president of medical affairs at Franciscan Health, to get his reaction to the news.
See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
71 Listeners
37 Listeners
13 Listeners
1 Listeners
4 Listeners
3 Listeners
3 Listeners
2 Listeners
1 Listeners